NeuroVision Acquires Durin Life Sciences to Expand Neurodegenerative Diagnostics Platform

▤ Summary

NeuroVision Imaging acquired Durin Life Sciences to combine Durin's blood-based diagnostic tests with NeuroVision's retinal imaging and BrainHealth.net telehealth platform. The combined company will operate under the NeuroVision name with CEO Steven Verdooner remaining in charge and Ric Edelman joining the board. The integrated platform aims to enable earlier detection and longitudinal monitoring of Alzheimer’s, Parkinson’s disease, and ALS by pairing less-invasive blood tests with remote imaging, assessment, and care coordination. Financial terms were not disclosed, and the deal positions the company to build an end-to-end neurodiagnostics and patient-management ecosystem amid rising demand for scalable, noninvasive neurological testing.

▦ Linked Companies